The World Health Organization approved Sinovac's CoronaVac coronavirus vaccine for emergency use. It was recommended for people over 18 years of age on a two-dosing schedule, with an interval of two to four weeks.
The WHO report says that, according to the results of the test, the vaccine prevented symptomatic disease in 51% of those vaccinated, and severe form and hospitalization—in 100%.
The organization reported that only a few elderly people took part in the study, so it is impossible to assess how effective the vaccine is for people over 60 years old. At the same time, WHO recommended vaccinating elderly people with it, since there is enough other data from different countries showing that the medication is effective.
CoronaVac can now provide its medications to the global COVAX initiative, and that will expedite vaccine certification in different countries.
Sinovac vaccine (CoronaVac) in Ukraine
According to Minister of Health Viktor Lyashko, those Ukrainians who received two doses of CoronaVac vaccine will obtain international vaccination passports. He wrote about this on his Facebook, adding that Ukraine had signed contracts for the supply of 1.9 million doses of this medication.
"The WHO endorsement of CoronaVac allows an international vaccination certificate to be granted to anyone who has completed the full course of vaccinations."
Viktor Liashko
Chief Sanitary Doctor
With what vaccinations it will be allowed to enter EU
So far, the European Union has approved four vaccines:
- AstraZeneca;
- Pfizer/BioNTech;
- Moderna;
- Johnson & Johnson.
As for the CoronaVac vaccine, the EU has yet to decide whether to allow entry to those who have been vaccinated with the medication.
Read also
Public consultations and restoration. What is Shulyak talking about behind the scenes
Ukraine's Recovery: How to Change Critically Low Citizen Engagement Indicators?
The future has already arrived: blockchain technologies in the global economy and everyday life
